Drug-resistant urinary tract infections spreading worldwide

Dec 28, 2009

A sudden worldwide increase in an antibiotic-resistant bacterium is cause for concern, according to a review in f1000 Medicine Reports.

Faculty of 1000 member Dr Johann Pitout, of the Department of and Laboratory Medicine, University of Calgary, urges the medical community to monitor the spread of a multi-drug resistant bacterium before it becomes necessary to use more powerful as a first response.

Extended-spectrum β-lactamases (ESBLs) are bacterially-produced enzymes that confer resistance to penicillin-type antibiotics. ESBLs have been commonly linked to nosocomial infections, which are generally treated with intravenously-administered antibiotics such as the carbapenems.

However, in recent years there has been a drastic increase in community-acquired infections, caused by a single strain of ESBL-producing E. coli. Dr Pitout suggests that the rapid spread of this particular strain is due, at least in part, to international travel through high-risk areas such as the Indian subcontinent.

Using carbapenems as the first response to such infections increases the risk of inducing resistance to them in the community, nullifying some of our most powerful anti-bacterial strategies. Dr Pitout recommends that the medical community should use existing methods to identify infections caused by ESBL-producing bacteria, and empirically test the efficacy of other antibiotics in treating community-acquired infections.

Dr Pitout concludes, "If this emerging public health threat is ignored … the medical community may be forced to use the carbapenems as the first choice for the empirical treatment of serious [community-acquired UTIs]."

Explore further: Study provides new perspectives on the current Clostridium difficile epidemic

Provided by Faculty of 1000: Biology and Medicine

4.2 /5 (6 votes)
add to favorites email to friend print save as pdf

Related Stories

C. difficile and antibiotics not necessarily linked

Oct 07, 2008

The latest study by Dr. Sandra Dial from the Research Institute of the MUHC, McGill University, and Attending Staff in the Intensive Care Unit at the Jewish General Hospital, questions the assumption held by a vast majority ...

New study finds MRSA on the rise in hospital outpatients

Nov 24, 2009

The community-associated strain of the deadly superbug MRSA -- an infection-causing bacteria resistant to most common antibiotics -- poses a far greater health threat than previously known and is making its way into hospitals, ...

Nanotechnology used to probe effectiveness of antibiotics

Feb 04, 2009

A group of researchers led by scientists from the London Centre for Nanotechnology, in collaboration with a University of Queensland researcher, have discovered a way of using tiny nano-probes to help understand how an antibiotic ...

Recommended for you

Diseases of another kind

9 hours ago

The drought that has the entire country in its grip is affecting more than the color of people's lawns. It may also be responsible for the proliferation of a heat-loving amoeba commonly found in warm freshwater bodies, such ...

User comments : 0